The adiponectin testing market is projected to expand its roots in the global market at a CAGR of 7.9% during the forecast period 2022 to 2032. The marketholds a valuation of USD 45.11 Billion in 2022 and is expected to cross USD 89 billion by 2032.
| Attributes | Details |
|---|---|
| Adiponectin Testing Market CAGR | 7.9% |
| Adiponectin Testing Market (2022) | USD 45.11 Billion |
| Adiponectin Testing Market (2032) | USD 89 Billion |
The rising sales of adiponectin testing kits can be attributed to the pivotal role in the pathogenesis of dyslipidemia, and the presence of adiponectin affects HDL and LDL metabolism.
Adiponectin is mainly used to regulate the metabolism of energy substrate and body composition, holding a huge influence over the body. Therefore, the demand for adiponectin testing kits is on the surge.
In addition, higher sales of adiponectin testing kits are also on account of the use of adiponectin ELISA kits and enzyme immunoassay kits for the diagnoses and research purposes of adiponectin.
Increasing healthcare awareness, among the people, especially in developing regions, is expected to augment the demand for adiponectin testing kits in the near future.
Furthermore, sales of adiponectin testing kits are on the surge as adiponectin plays a major role in modulating lipid and glucose metabolism.
Decreased adiponectin levels are generally found in genetic and diet-induced murine models of obesity. Hence, it becomes imperative for one to keep a check on the level of adiponectin, propelling the demand for adiponectin testing kits, and mediating insulin action or resistance.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The increasing research and development activities are the main factor that is responsible for increasing the demand for adiponectin testing kits.
An increasing number of research laboratories and diagnostic laboratories is expected to augment the sales of adiponectin testing kits.
Sales of adiponectin testing kits are growing owing to other factors, such as the increasing number of hospitals and increasing healthcare expenditure.
Increasing disposable income in various countries is also considered a major fuller in demand for adiponectin testing kits.
There are a few factors that can hinder the overall demand for adiponectin testing kits. One of them is the high cost of adiponectin tests, and the same is expected to impede the sales of adiponectin testing kits. Lack of awareness in some of the developing regions and poor availability of medical facilities in a few developing economies are also limiting the demand for adiponectin testing kits.
Sales of adiponectin testing kits are on the surge as these are simple and easy to perform and are majorly used for research purposes. The adiponectin kits are very convenient to use and hence, can increase the demand for adiponectin testing kits.
On the basis of geography, the global adiponectin testing market has been segmented into several key regions, i.e., North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA.
North America is expected to hold a large adiponectin testing market share due to the presence of a large number of hospitals and advanced healthcare infrastructure.
Europe is also expected to hold a large adiponectin testing market share, and the same can be attributed to the increasing population.
The Asia Pacific is also expected to show significant growth in the sales of adiponectin testing kits due to the increasing research and developmental activities.
The manufacturing companies use different strategies, like new product launches and acquisitions, which are expected to augment the adiponectin testing market share. The report consists of key players contributing to the adiponectin testing market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions.
Some of the key players present in the global adiponectin testing market are Eagle Biosciences, Boster Biological Technology, Merck KGaA, Thermo Fisher Scientific Inc., Biorad laboratories, Stratech, etc.
| Report Attribute | Details |
|---|---|
| Base year for estimation | 2021 |
| Historical data | 2015 to 2021 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Type, End Use and Region |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | Eagle Biosciences; Boster Biological Technology; Merck KGaA; Thermo fisher Scientific Inc.; Biorad laboratories etc.; Stratech etc. |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
High cost of adiponectin test and the uneasy implementation are expected to restrain the demand for adiponectin testing kits.
North America is expected to hold a large adiponectin testing market share owing to the presence of advanced healthcare infrastructure.
Some of the key players present in global adiponectin testing market are Eagle Biosciences, Boster Biological Technology, Merck KGaA, Thermo fisher Scientific Inc., Biorad laboratories etc. Stratech etc.
| Market CAGR (2023 to 2033) | 6.8% |
|---|---|
| Market Size (2023) | USD 3.7 billion |
| Market Size (2033) | USD 7.2 billion |
| Market Value in 2021 | USD 2,855.50 Million |
|---|---|
| Market Value in 2032 | USD 5,092.47 Million |
| Market CAGR (2022 to 2032) | 5.4% |
Explore In-vitro Diagnostics Devices Insights
View Reports
Adiponectin Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
